Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
Citation
Vickers , M A , Wilkie , G M , Robinson , N , Rivera , N , Haque , T , Crawford , D H , Barry , J , Fraser , N , Turner , D M , Robertson , V , Dyer , P , Flanagan , P , Newlands , H R , Campbell , J & Turner , M 2014 , ' Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease ' , British Journal of Haematology , vol. 167 , no. 3 , pp. 402-410 . https://doi.org/10.1111/bjh.13051
Rights
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0/